Neil Feldman, DPM
Foot Surgery · Worcester, MANPI 1104804640
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,400 of the $3,551 with a category attached, or 67.6%. Kairos Surgical Inc accounts for 68.8% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $2,537 and has fallen 92.3% since, to $196 in 2025.
Across 34 payments — averaging $104.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kairos Surgical Inc$2K
- Zimmer Biomet$337
- Averitas Pharma Inc.$244
- Saluda Medical Americas, Inc.$117
- Abbott$103
- Orthofix Medical, Inc.$88
- plus $218 from 9 others
What the payments were for
- Food & beverage$1,15132%
- Education$2,40068%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kairos Surgical Inc | 5 | $2,444 |
| Zimmer Biomet | 8 | $337 |
| Averitas Pharma Inc. | 6 | $244 |
| Saluda Medical Americas, Inc. | 1 | $117 |
| Abbott | 1 | $103 |
| Orthofix Medical, Inc. | 4 | $88 |
| Vertex | 1 | $46 |
| Innovation Technologies Inc | 1 | $32 |
| Powerlink AI, Inc. | 1 | $30 |
| Convatec Inc. | 1 | $23 |
| Organogenesis Inc. | 1 | $20 |
| Acumed LLC | 1 | $18 |
| Stryker | 1 | $17 |
| Bioventus LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$117
- TWISTOFF TWISTOFF SCREW$112
- PROCLAIM$103
How this compares
$3,551 in reported general payments places this provider in the 80th percentile of 41 foot surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QutenzaCapsaicin/Skin Cleanser | 12 | $41,707 |
| Diclofenac Sodium | 28 | $632 |
| Celecoxib | 19 | $169 |
| Terbinafine Hcl | 23 | $145 |
| Cephalexin | 14 | $55 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Worcester
- John ScheffelWorcester$192
- Robert GrondinWorcester$155
- Adam LandsmanBoston$385K
- Mark RoseNatick$9K
- Jamey AllenWoburn$8K
- Ewald MendeszoonWest Roxbury$6K
- Christopher LockeBoston$6K
- Jurgen FernandezLynn$4K
- Justin OgbonnaBoston$4K
- Wei TsengBoston$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.